FDA Grand Rounds: Detection of transmissible spongiform encephalopathy agents in biological products using protein aggregation assays

Thursday, February 13, 2020
12:00 p.m. - 1:00 p.m. EST
WO Building 32,  Room 1243 (or via webcast)
 
Presented by

Luisa Gregori, PhD
Chemist and Principal Investigator
Lab of Bacterial & Transmissible Spongiform Encephalopathy Agents, Division of Emerging and Transfusion Transmitted Diseases (DETTD), CBER

www.FDA.gov/GrandRounds: For more information and to register